American Society of Clinical Oncology

SHERPA: White

People

  1. Danila
    Danila
  2. Fine
    Fine
  3. Fox
    Fox
  4. Morris
    Morris
  5. Rathkopf
    Rathkopf
  6. Rosen
    Rosen
  7. Scher
    Scher
  8. Slovin
    Slovin

Groups

  1. Breast Medicine Service (1)
  2. Department of Medicine (1)
  3. GSK Faculty (1)
  4. Genitourinary Oncology Service (1)
  5. Hematologic Malignancies, Division of (1)
  6. Molecular Imaging and Therapy Service (1)
  7. Molecular Pharmacology and Chemistry Program Faculty (1)
  8. Radiology, Department of (1)
  9. Sloan Kettering Institute Faculty (1)
  10. Solid Tumor Oncology Division (1)
Search Within
  1. "Michael Morris"
  2. "Jay Chudow"
Formats
  1. Meeting Abstract (1)
Groups
  1. Breast Medicine Service (1)
  2. Department of Medicine (1)
  3. GSK Faculty (1)
  4. Genitourinary Oncology Service (1)
  5. Hematologic Malignancies, Division of (1)
  6. Molecular Imaging and Therapy Service (1)

More Groups

People
  1. Dana Rathkopf (1)
  2. Daniel Danila (1)
  3. Howard Scher (1)
  4. Jay Chudow (1)
  5. Josef Fox (1)
  6. Michael Morris (1)

More People

Years
  1. 2010 (1)
Publications
  1. Journal of Clinical Oncology (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Chudow, J. J.; Morris, M. J.; Slovin, S. F.; Fine, S.; Fox, J. J.; Larson, S. M.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save